Journal of Human and Animal Intestines

Journal of Human and Animal Intestines

Journal of Human and Animal Intestines – Data Archiving Permissions

Open Access & Peer-Reviewed

Submit Manuscript
JHAI Publishing

Data Archiving Permissions

Responsible data sharing supports reproducibility and trust in gastrointestinal research.

DATA Transparent Access
PRIV Patient Privacy
REUSE Reusable Evidence
Data

Data Availability Statements

Each submission requires a statement describing where data are stored and how they can be accessed.

  • Public repositories with persistent identifiers
  • Controlled access repositories for sensitive clinical data
  • Data available from the corresponding author on reasonable request
  • Data included within the article or supplementary files

Statements should specify access conditions, embargo periods, and any data use agreements.

Repositories

Repository Guidance

Select repositories that provide stable access and clear reuse terms.

General Repositories

Zenodo, Figshare, Dryad, or OSF for broad access.

Clinical Data

Controlled access repositories with governance oversight.

Institutional Repositories

Persistent identifiers and clear metadata for compliance.

Code Repositories

Archive analysis scripts with version details.

For imaging or waveform data, include metadata describing acquisition settings and processing steps.

Protection

Deidentification and Security

Clinical datasets must be deidentified and protected using appropriate governance controls.

  • Remove direct identifiers and assess reidentification risk
  • Document the deidentification method used
  • Use controlled access for sensitive imaging or genomic data
  • Describe data use agreements and access criteria

When datasets cannot be shared publicly, provide clear access steps and a contact point for requests.

Statements

Data Availability Statements

Provide clear and specific data availability language.

Statements should identify the repository, persistent identifier, and access conditions. Use consistent language across the manuscript and supplementary files.

If data are available on request, explain the criteria and expected response timeline to support transparency.

  • Repository name and DOI or accession number
  • Embargo end date if applicable
  • Access request process and governing body
  • Limits due to privacy or consent
Privacy

Privacy and Consent

Protect patient privacy and confirm consent for data sharing.

Sensitive datasets should use controlled access with documented governance procedures.

For clinical images, remove identifying details and document consent for publication.

Documentation

Documentation and Formats

Provide data dictionaries, readme files, and consistent units.

Use open formats such as CSV for tables and include code for analytical workflows when possible.

Clear file organization reduces delays when access requests are approved and supports reproducibility.

Include a brief summary of dataset structure to help reviewers and secondary users interpret files quickly.

Code

Code and Analytical Workflows

Sharing analysis scripts supports verification and reuse.

Include software versions, package details, and computational settings used in analysis. Workflow documentation helps reviewers and secondary users reproduce results.

When code cannot be shared, provide detailed methodological descriptions and specify any proprietary tools.

Access

Governance and Access Requests

Controlled access datasets should describe application steps and review criteria.

  • Data access committee or review process
  • Eligibility criteria for secondary use
  • Expected response timelines
  • Required data use agreements

Embargo periods should include a clear end date and justification to support responsible sharing.

Embargo

Embargo and Timing

Embargo periods may be used when justified by ongoing analyses or participant protections.

Provide the embargo end date and the reason for any delay in release. Clear timing helps secondary researchers plan reuse and supports compliance reporting.

If data are released in stages, describe what is available immediately and what will follow.

Embargo requests should be consistent with funder and institutional policies.

Retention

Retention and Versioning

Maintain archived datasets for a reasonable period and document version updates.

Clear versioning supports reproducibility and long term evaluation of intestinal outcomes.

Document file relationships and provide updated metadata when datasets change.

Retain documentation that explains changes between versions to help secondary users interpret updates.

Reuse

Reuse Terms and Licensing

Clear reuse terms help secondary researchers understand permitted uses.

Select repository licenses that align with ethical requirements and data use agreements. Indicate any restrictions that apply to commercial reuse or derivative analyses.

Transparent reuse terms encourage responsible collaboration and protect participant privacy.

If reuse requires approval, describe the review criteria and expected response timelines.

Summary

Data Sharing Summary

Responsible archiving strengthens trust and improves gastrointestinal outcomes.

Data sharing must respect privacy, consent, and legal requirements.

Provide clear access instructions and contact details for restricted datasets.

Well documented datasets support validation studies and meta analyses.

Clear reuse terms help secondary researchers plan responsible analyses.

Prepare a Data Ready Submission

Responsible archiving strengthens trust and improves gastrointestinal outcomes.

Contact: [email protected]